Ovarian cancer in endometriosis: Molecular biology, pathology, and clinical management

International Journal of Clinical Oncology

Volumn 14, Issue 5, 2009, Pages 383-391

  Mandai, Masaki ^a   Yamaguchi, Ken ^a   Matsumura, Noriomi ^a   Baba, Tsukasa ^a   Konishi, Ikuo ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Endometriosis; Microarray; Ovarian cancer; Oxidative stress; Pathogenesis

Indexed keywords

ESTRADIOL; HEPATOCYTE NUCLEAR FACTOR 1; K RAS PROTEIN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN P53;

CYTOLOGY; ENDOMETRIOSIS; GENE MUTATION; HETEROZYGOSITY LOSS; HISTOLOGY; HUMAN; MICROARRAY ANALYSIS; MICROENVIRONMENT; MOLECULAR BIOLOGY; OVARY CANCER; OXIDATIVE STRESS; PHENOTYPE; PRIORITY JOURNAL; REVIEW; RISK FACTOR;

ADENOCARCINOMA, CLEAR CELL; CARCINOMA, ENDOMETRIOID; CELL TRANSFORMATION, NEOPLASTIC; ENDOMETRIOSIS; EVIDENCE-BASED MEDICINE; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC PREDISPOSITION TO DISEASE; HUMANS; OVARIAN NEOPLASMS; PRACTICE GUIDELINES AS TOPIC; PRECANCEROUS CONDITIONS; RISK ASSESSMENT; RISK FACTORS;

EID: 70350501512     PISSN: 13419625     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10147-009-0935-y     Document Type: Review

References (77)

1. S.L. Maines-Bandiera N. Auersperg 1997 Increased E-cadherin expression in ovarian surface epithelium: an early step in metaplasia and dysplasia? Int J Gynecol Pathol 16 250 255 1:STN:280:DyaK1c%2FotFCntg%3D%3D 9421091
2. J. Yoshida A. Horiuchi N. Kikuchi, et al. 2009 Changes in the expression of E-cadherin repressors, Snail, Slug, SIP1, and Twist, in the development and progression of ovarian carcinoma: the important role of Snail in ovarian tumorigenesis and progression Med Mol Morphol 42 82 91 10.1007/s00795-008-0436-5 1:CAS:528:DC%2BD1MXntlOgsbs%3D 19536615
3. T. Kusakari M. Kariya M. Mandai, et al. 2003 C-erbB-2 or mutant Ha-ras induced malignant transformation of immortalized human ovarian surface epithelial cells in vitro Br J Cancer 89 2293 2298 10.1038/sj.bjc.6601423 1:CAS:528:DC%2BD3sXpvVShuro%3D 14676809 (Pubitemid 38168014)
4. M. Nitta H. Katabuchi H. Ohtake, et al. 2001 Characterization and tumorigenicity of human ovarian surface epithelial cells immortalized by SV40 large T antigen Gynecol Oncol 81 10 17 10.1006/gyno.2000.6084 1:CAS:528:DC%2BD3MXit1antrk%3D 11277643 (Pubitemid 32368071)
5. D.S. McMeekin R.A. Burger A. Manetta, et al. 1995 Endometrioid adenocarcinoma of the ovary and its relationship to endometriosis Gynecol Oncol 59 81 86 10.1006/gyno.1995.1271 1:STN:280:DyaK28%2Fhs1ejsQ%3D%3D 7557621
6. S. Komiyama D. Aoki E. Tominaga, et al. 1999 Prognosis of Japanese patients with ovarian clear cell carcinoma associated with pelvic endometriosis: clinicopathologic evaluation Gynecol Oncol 72 342 346 10.1006/gyno.1998.5284 1:STN:280:DyaK1M7msVWgug%3D%3D 10053105 (Pubitemid 29118191)
7. M. Erzen S. Rakar B. Klancnik K. Syrjänen 2001 Endometriosis- associated ovarian carcinoma (EAOC): an entity distinct from other ovarian carcinomas as suggested by a nested case-control study Gynecol Oncol 83 100 108 10.1006/gyno.2001.6382 1:STN:280:DC%2BD3MrjvV2mtg%3D%3D 11585420 (Pubitemid 32959885)
8. T. Van Gorp F. Amant P. Neven, et al. 2004 Endometriosis and the development of malignant tumours of the pelvis. A review of literature Best Pract Res Clin Obstet Gynaecol 18 349 371 10.1016/j.bpobgyn.2003.03.001 15157647 (Pubitemid 38786637)
9. R.E. Scully 1987 Classification of human ovarian tumors Environ Health Perspect 73 15 25 10.2307/3430594 1:STN:280:DyaL1c%2FivFarsQ%3D%3D 3665859
10. Japan Society of Obstetrics and Gynecology and the Japanese Society of Pathology (1990) The general rules for clinical and pathological management of ovarian tumors. Kanehara, Tokyo
11. M. Nilbert T. Pejovic N. Mandahl, et al. 1995 Monoclonal origin of endometriotic cysts Int J Gynecol Cancer 5 61 63 10.1046/j.1525-1438.1995. 05010061.x 11578455
12. M. Tamura T. Fukaya T. Murakami, et al. 1998 Analysis of clonality in human endometriotic cysts based on evaluation of X chromosome inactivation in archival formalin-fixed, paraffin-embedded tissue Lab Invest 78 213 218 1:STN:280:DyaK1c7ktlanug%3D%3D 9484719
13. H. Jimbo Y. Hitomi H. Yoshikawa, et al. 1997 Evidence for monoclonal expansion of epithelial cells in ovarian endometrial cysts Am J Pathol 150 1173 1178 1:STN:280:DyaK2s3kvFSlug%3D%3D 9094973
14. Y. Wu Z. Basir A. Kajdacsy-Balla, et al. 2003 Resolution of clonal origins for endometriotic lesions using laser capture microdissection and the human androgen receptor (HUMARA) assay Fertil Steril 79 Suppl1 710 717 10.1016/S0015-0282(02)04821-5 12620481 (Pubitemid 36279674)
15. D. Mayr G. Amann C. Siefert, et al. 2003 Does endometriosis really have premalignant potential? A clonal analysis of lasermicrodissected tissue FASEB J 17 693 695 1:CAS:528:DC%2BD3sXislGmuro%3D 12594178
16. X. Jiang A. Hitchcock E.J. Bryan, et al. 1996 Microsatellite analysis of endometriosis reveals loss of heterozygosity at candidate ovarian tumor suppressor gene loci Cancer Res 56 3534 3539 1:CAS:528:DyaK28Xks1elsbw%3D 8758923
17. J.C. Shin H.L. Ross S. Elias, et al. 1997 Detection of chromosomal aneuploidy in endometriosis by multi-color fluorescence in situ hybridization (FISH) Hum Genet 100 401 406 10.1007/s004390050524 1:CAS:528:DyaK2sXkvF2msrc%3D 9272163 (Pubitemid 27386848)
18. J. Gogusev J. Bouquet de Jolinière L. Telvi, et al. 2000 Genetic abnormalities detected by comparative genomic hybridization in a human endometriosis-derived cell line Mol Hum Reprod 6 821 827 10.1093/molehr/6.9.821 1:STN:280:DC%2BD3M%2FitVaisg%3D%3D 10956554
19. F.Z. Bischoff M. Heard J.L. Simpson 2002 Somatic DNA alterations in endometriosis: high frequency of chromosome 17 and p53 loss in late-stage endometriosis J Reprod Immunol 55 49 64 10.1016/S0165-0378(01)00131-0 1:CAS:528:DC%2BD38XksVSgs70%3D 12062821 (Pubitemid 34626151)
20. N. Sato H. Tsunoda M. Nishida, et al. 2000 Loss of heterozygosity on 10q23.3 and mutation of the tumor suppressor gene PTEN in benign endometrial cyst of the ovary: possible sequence progression from benign endometrial cyst to endometrioid carcinoma and clear cell carcinoma of the ovary Cancer Res 60 7052 7056 1:CAS:528:DC%2BD3MXjsVOhsA%3D%3D 11156411
21. J. Sampson 1925 Endometrial carcinoma of the ovary, arising in endometrial tissue in that organ Arch. Surg 10 1 72
22. R.B. Scott 1953 Malignant changes in endometriosis Obstet Gynecol 2 283 289 1:STN:280:DyaG2c%2FgvVKksg%3D%3D 13087921
23. R. Sainz de la Cuesta J.H. Eichhorn L.W. Rice, et al. 1996 Histologic transformation of benign endometriosis to early epithelial ovarian cancer Gynecol Oncol 60 238 244 10.1006/gyno.1996.0032 1:STN:280:DyaK287ptVyqsw%3D%3D 8631545 (Pubitemid 26058768)
24. X. Jiang S.J. Morland A. Hitchcock, et al. 1998 Allelotyping of endometriosis with adjacent ovarian carcinoma reveals evidence of a common lineage Cancer Res 58 1707 1712 1:CAS:528:DyaK1cXisleruro%3D 9563487
25. A.H. Prowse S. Manek R. Varma, et al. 2006 Molecular genetic evidence that endometriosis is a precursor of ovarian cancer Int J Cancer 119 556 562 10.1002/ijc.21845 1:CAS:528:DC%2BD28Xmtlyjsrc%3D 16506222 (Pubitemid 43955708)
26. P.B. Clement 2007 The pathology of endometriosis: a survey of the many faces of a common disease emphasizing diagnostic pitfalls and unusual and newly appreciated aspects Adv Anat Pathol 14 241 260 10.1097/PAP.0b013e3180ca7d7b 17592255 (Pubitemid 47012362)
27. M. Fukunaga S. Ushigome 1998 Epithelial metaplastic changes in ovarian endometriosis Mod Pathol 11 784 788 1:STN:280:DyaK1czosFClsQ%3D%3D 9720509
28. F. Prefumo F. Todeschini E. Fulcheri, et al. 2002 Epithelial abnormalities in cystic ovarian endometriosis Gynecol Oncol 84 280 284 10.1006/gyno.2001.6529 11812087 (Pubitemid 34136780)
29. B. Czernobilsky W.J. Morris 1979 A histologic study of ovarian endometriosis with emphasis on hyperplastic and atypical changes Obstet Gynecol 53 318 323 1:STN:280:DyaE1M7jsFOnug%3D%3D 424103
30. A. LaGrenade S.G. Silverberg 1988 Ovarian tumors associated with atypical endometriosis Hum Pathol 19 1080 1084 10.1016/S0046-8177(88)80090-X 1:STN:280:DyaL1czjtVSnsQ%3D%3D 3417292 (Pubitemid 18239509)
31. J.D. Seidman 1996 Prognostic importance of hyperplasia and atypia in endometriosis Int J Gynecol Pathol 15 1 9 1:STN:280:DyaK2s%2FgsFWhug%3D%3D 8852439
32. S. Ogawa T. Kaku S. Amada, et al. 2000 Ovarian endometriosis associated with ovarian carcinoma: a clinicopathological and immunohistochemical study Gynecol Oncol 77 298 304 10.1006/gyno.2000.5765 1:STN:280:DC%2BD3c3kvFWisQ%3D%3D 10785482 (Pubitemid 30317153)
33. M. Fukunaga K. Nomura E. Ishikawa, et al. 1997 Ovarian atypical endometriosis: its close association with malignant epithelial tumours Histopathology 30 249 255 10.1046/j.1365-2559.1997.d01-592.x 1:STN:280:DyaK2s3ksVWntw%3D%3D 9088954
34. R.C. Stern R. Dash R.C. Bentley, et al. 2001 Malignancy in endometriosis: frequency and comparison of ovarian and extraovarian types Int J Gynecol Pathol 20 133 139 10.1097/00004347-200104000-00004 1:STN:280:DC%2BD3MvjsVyqsA%3D%3D 11293158
35. S.C. Modesitt G. Tortolero-Luna J.B. Robinson, et al. 2002 Ovarian and extraovarian endometriosis-associated cancer Obstet Gynecol 100 788 795 10.1016/S0029-7844(02)02149-X 12383550 (Pubitemid 35300039)
36. J.L. Rutgers R.E. Scully 1988 Ovarian mullerian mucinous papillary cystadenomas of borderline malignancy. A clinicopathologic analysis Cancer 61 340 348 10.1002/1097-0142(19880115)61:2<340::AID-CNCR2820610225>3.0.CO;2-U 1:STN:280:DyaL1c%2FnvF2jsQ%3D%3D 3334969
37. J.L. Rutgers R.E. Scully 1988 Ovarian mixed-epithelial papillary cystadenomas of borderline malignancy of mullerian type. A clinicopathologic analysis Cancer 61 546 554 10.1002/1097-0142(19880201)61:3<546::AID- CNCR2820610321>3.0.CO;2-I 1:STN:280:DyaL1c7gvFagtg%3D%3D 3338022
38. K.R. Lee M.R. Nucci 2003 Ovarian mucinous and mixed epithelial carcinomas of mullerian (endocervical-like) type: a clinicopathologic analysis of four cases of an uncommon variant associated with endometriosis Int J Gynecol Pathol 22 42 51 10.1097/00004347-200301000-00010 12496697 (Pubitemid 36014275)
39. L.M. Griffith M.L. Carcangiu 1991 Sex cord tumor with annular tubules associated with endometriosis of the fallopian tube Am J Clin Pathol 96 259 262 1:STN:280:DyaK3MzitVyltA%3D%3D 1862780
40. M.T. Manipadam A. Munemane P. Emmanuel, et al. 2008 McCluggage WG. Ovarian adenosarcoma with extensive deciduoid morphology arising in endometriosis: a case report Int J Gynecol Pathol 27 398 401 10.1097/PGP.0b013e318165e2d0 18580317
41. R. Ali-Fehmi I. Khalifeh S. Bandyopadhyay, et al. 2006 Patterns of loss of heterozygosity at 10q23.3 and microsatellite instability in endometriosis, atypical endometriosis, and ovarian carcinoma arising in association with endometriosis Int J Gynecol Pathol 25 223 229 10.1097/01.pgp.0000192274.44061.36 16810057 (Pubitemid 44610034)
42. R. Sainz de la Cuesta M. Izquierdo M. Cañamero, et al. 2004 Increased prevalence of p53 overexpression from typical endometriosis to atypical endometriosis and ovarian cancer associated with endometriosis Eur J Obstet Gynecol Reprod Biol 113 87 93 10.1016/S0301-2115(03)00367-1 1:CAS:528:DC%2BD2cXhs12ntb4%3D 15036718 (Pubitemid 38281201)
43. F. Nezhat C. Cohen J. Rahaman, et al. 2002 Comparative immunohistochemical studies of bcl-2 and p53 proteins in benign and malignant ovarian endometriotic cysts Cancer 94 2935 2940 10.1002/cncr.10566 1:CAS:528:DC%2BD38XkvVGlt7o%3D 12115382 (Pubitemid 34547693)
44. D.M. Dinulescu T.A. Ince B.J. Quade, et al. 2005 Role of K-ras and Pten in the development of mouse models of endometriosis and endometrioid ovarian cancer Nat Med 11 63 70 10.1038/nm1173 1:CAS:528:DC%2BD2MXptVSm 15619626 (Pubitemid 40215839)
45. M. Martini M. Ciccarone G. Garganese, et al. 2002 Possible involvement of hMLH1, p16(INK4a) and PTEN in the malignant transformation of endometriosis Int J Cancer 102 398 406 10.1002/ijc.10715 1:CAS:528:DC%2BD38Xos1ajtbw%3D 12402310 (Pubitemid 35265880)
46. K. Obata H. Hoshiai 2000 Common genetic changes between endometriosis and ovarian cancer Gynecol Obstet Invest 50 Suppl1 39 43 10.1159/000052877 1:CAS:528:DC%2BD3cXovVeksL8%3D 11093060
47. T. Yagyu Y. Tsuji S. Haruta, et al. 2006 Activation of mammalian target of rapamycin in postmenopausal ovarian endometriosis Int J Gynecol Cancer 16 1545 1551 10.1111/j.1525-1438.2006.00625.x 1:STN:280:DC%2BD28vmtFyltw%3D%3D 16884363 (Pubitemid 44060377)
48. T. Okuda J. Otsuka A. Sekizawa, et al. 2003 p53 mutations and overexpression affect prognosis of ovarian endometrioid cancer but not clear cell cancer Gynecol Oncol 88 318 325 10.1016/S0090-8258(02)00149-X 1:CAS:528:DC%2BD3sXitVyks7c%3D 12648581 (Pubitemid 36331984)
49. S. Amemiya A. Sekizawa J. Otsuka, et al. 2004 Malignant transformation of endometriosis and genetic alterations of K-ras and microsatellite instability Int J Gynaecol Obstet 86 371 376 10.1016/j.ijgo.2004.04.036 1:CAS:528: DC%2BD2cXmvFWkt7k%3D 15325855 (Pubitemid 39119945)
50. J. Otsuka T. Okuda A. Sekizawa, et al. 2004 K-ras mutation may promote carcinogenesis of endometriosis leading to ovarian clear cell carcinoma Med Electron Microsc 37 188 192 10.1007/s00795-004-0252-5 15449112 (Pubitemid 40576037)
51. A. Tsuchiya M. Sakamoto J. Yasuda, et al. 2003 Expression profiling in ovarian clear cell carcinoma: identification of hepatocyte nuclear factor-1 beta as a molecular marker and a possible molecular target for therapy of ovarian clear cell carcinoma Am J Pathol 163 2503 2512 1:CAS:528:DC%2BD2cXkslOm 14633622
52. N. Kato S. Sasou T. Motoyama 2006 Expression of hepatocyte nuclear factor-1beta (HNF-1beta) in clear cell tumors and endometriosis of the ovary Mod Pathol 19 83 89 10.1038/modpathol.3800492 1:CAS:528:DC%2BD2MXhtlSqu7zM 16258507 (Pubitemid 43250982)
53. D. Oxholm U.B. Knudsen N. Kryger-Baggesen, et al. 2007 Postmenopausal endometriosis Acta Obstet Gynecol Scand. 4 1 7
54. I. Reintoft A.P. Lange A. Skipper 1974 Coincidence of granulosa-cell tumour of ovary and development of carcinoma in rectal endometriosis Acta Obstet Gynecol Scand 53 185 189 1:STN:280:DyaE2c7ktlSltA%3D%3D 4822349
55. I. Cohen Y. Beyth R. Tepper, et al. 1996 Ovarian tumors in postmenopausal breast cancer patients treated with tamoxifen Gynecol Oncol 60 54 58 10.1006/gyno.1996.0011 1:CAS:528:DyaK28XpsF2itA%3D%3D 8557228 (Pubitemid 26028457)
56. K. Okugawa T. Hirakawa S. Ogawa, et al. 2002 Ovarian endometrioid adenocarcinoma arising from an endometriotic cyst in a postmenopausal woman under tamoxifen therapy for breast cancer: a case report Gynecol Oncol 87 231 234 10.1006/gyno.2002.6824 12477460 (Pubitemid 36044095)
57. G.M. Zanetta M.J. Webb H. Li G.L. Keeney 2000 Hyperestrogenism: a relevant risk factor for the development of cancer from endometriosis Gynecol Oncol 79 18 22 10.1006/gyno.2000.5905 1:STN:280:DC%2BD3M%2FgvFSmsA%3D%3D 11006024 (Pubitemid 30780150)
58. S. Lavery M. Gillmer 2001 Malignant transformation of residual endometriosis in women on unopposed oestrogen hormone replacement therapy BJOG 108 1106 1107 10.1016/S0306-5456(01)00238-8 1:STN:280:DC%2BD3MnltV2itQ%3D%3D 11702846 (Pubitemid 32971748)
59. N.F. Soliman T.C. Hillard 2006 Hormone replacement therapy in women with past history of endometriosis Climacteric 9 325 335 10.1080/13697130600868711 1:CAS:528:DC%2BD28Xht1CmsrnL 17000581 (Pubitemid 44454524)
60. M.G. Del Carmen A.E. Smith Sehdev A.N. Fader, et al. 2003 Endometriosis-associated ovarian carcinoma: differential expression of vascular endothelial growth factor and estrogen/progesterone receptors Cancer 98 1658 1663 10.1002/cncr.11714 14534882 (Pubitemid 37238622)
61. S. Yamamoto H. Tsuda M. Takano, et al. 2008 Expression of platelet-derived growth factors and their receptors in ovarian clear-cell carcinoma and its putative precursors Mod Pathol 21 115 124 1:CAS:528: DC%2BD1cXhtVKjtbk%3D 18084257
62. F. Taniguchi T. Harada T. Iwabe, et al. 2008 Aberrant expression of keratinocyte growth factor receptor in ovarian surface epithelial cells of endometrioma Fertil Steril 89 478 480 10.1016/j.fertnstert.2007.02.060 1:CAS:528:DC%2BD1cXivFahu7c%3D 17482184 (Pubitemid 351215400)
63. M. Furuya T. Suyama H. Usui, et al. 2007 Up-regulation of CXC chemokines and their receptors: implications for proinflammatory microenvironments of ovarian carcinomas and endometriosis Hum Pathol 38 1676 1687 10.1016/j.humpath.2007.03.023 1:CAS:528:DC%2BD2sXhtF2lsb3F 17707463 (Pubitemid 47589091)
64. C. Uzan E. Darai A. Valent, et al. 2009 Status of HER1 and HER2 in peritoneal, ovarian and colorectal endometriosis and ovarian endometrioid adenocarcinoma Virchows Arch 454 525 529 10.1007/s00428-009-0755-5 1:CAS:528:DC%2BD1MXlt1SmtLk%3D 19294416
65. K. Yamaguchi M. Mandai S. Toyokuni, et al. 2008 Contents of endometriotic cysts, especially the high concentration of free iron, are a possible cause of carcinogenesis in the cysts through the iron-induced persistent oxidative stress Clin Cancer Res 14 32 40 10.1158/1078-0432.CCR-07-1614 1:CAS:528:DC%2BD1cXoslKq 18172249
66. S. Toyokuni 2009 Role of iron in carcinogenesis: cancer as a ferrotoxic disease Cancer Sci 100 9 16 10.1111/j.1349-7006.2008.01001.x 1:CAS:528:DC%2BD1MXhtlGguro%3D 19018762
67. M. Körner E. Burckhardt L. Mazzucchelli 2006 Higher frequency of chromosomal aberrations in ovarian endometriosis compared to extragonadal endometriosis: a possible link to endometrioid adenocarcinoma Mod Pathol 19 1615 1623 10.1038/modpathol.3800699 16980942 (Pubitemid 44789930)
68. A. Melin P. Sparén I. Persson A. Bergqvist 2006 Endometriosis and the risk of cancer with special emphasis on ovarian cancer Hum Reprod 21 1237 1242 10.1093/humrep/dei462 1:STN:280:DC%2BD283ovFShug%3D%3D 16431901
69. R.B. Ness F. Modugno 2006 Endometriosis as a model for inflammation-hormone interactions in ovarian and breast cancers Eur J Cancer 42 691 703 10.1016/j.ejca.2006.01.009 1:CAS:528:DC%2BD28Xjs1Grtro%3D 16531042
70. H. Kobayashi K. Sumimoto N. Moniwa, et al. 2007 Risk of developing ovarian cancer among women with ovarian endometrioma: a cohort study in Shizuoka, Japan Int J Gynecol Cancer 17 37 43 10.1111/j.1525-1438.2006.00754.x 1:STN:280:DC%2BD2s%2FpsVCjtw%3D%3D 17291229 (Pubitemid 46213967)
71. H. Kobayashi K. Sumimoto T. Kitanaka, et al. 2008 Ovarian endometrioma-risk factors of ovarian cancer development Eur J Obstet Gynecol Reprod Biol 138 187 193 10.1016/j.ejogrb.2007.06.017 18162283
72. C. Reimnitz E. Brand R.K. Nieberg, et al. 1988 Malignancy arising in endometriosis associated with unopposed estrogen replacement Obstet Gynecol 71 444 447 1:STN:280:DyaL1c7lslCisg%3D%3D 3279356
73. F. Nezhat M.S. Datta V. Hanson, et al. 2008 The relationship of endometriosis and ovarian malignancy: a review Fertil Steril 90 1559 1570 10.1016/j.fertnstert.2008.08.007 1:CAS:528:DC%2BD1cXhsVOhur3O 18993168
74. G. Debus I. Schuhmacher 2001 Endometrial adenocarcinoma arising during estrogenic treatment 17 years after total abdominal hysterectomy and bilateral salpingo-oophorectomy: a case report Acta Obstet Gynecol Scand 80 589 590 10.1034/j.1600-0412.2001.080006589.x 1:STN:280:DC%2BD3M3pvVeqsw%3D%3D 11380300 (Pubitemid 32521303)
75. F. Modugno R.B. Ness G.O. Allen, et al. 2004 Oral contraceptive use, reproductive history, and risk of epithelial ovarian cancer in women with and without endometriosis Am J Obstet Gynecol 191 733 740 10.1016/j.ajog.2004.03.035 15467532 (Pubitemid 39298101)
76. K. Takayama K. Zeitoun R.T. Gunby, et al. 1998 Treatment of severe postmenopausal endometriosis with an aromatase inhibitor Fertil Steril 69 709 713 10.1016/S0015-0282(98)00022-3 1:STN:280:DyaK1c3gsl2guw%3D%3D 9548162 (Pubitemid 28188468)
77. H.M. Fatemi H.A. Al-Turki E.G. Papanikolaou, et al. 2005 Successful treatment of an aggressive recurrent post-menopausal endometriosis with an aromatase inhibitor Reprod Biomed Online 11 455 457 1:STN:280: DC%2BD2MrpslWgsA%3D%3D 16274608